Parabens in Cosmetic Products
Parabens are widely used as preservatives in cosmetic and personal care products. Over the years, there have been some concerns related to the safety of parabens. The SCCS has published several opinions regarding the use of these ingredients in cosmetics, indicating the concentration levels they considered safe for human health. In the EU, some parabens can be safely used as preservatives, while others are prohibited in cosmetic products.

PARABENS

Parabens are important ingredients widely used as preservatives in different types of cosmetics and personal care products.

Preservatives are added to cosmetic and personal care products to reduce the risk of microbial contamination of the product and to ensure it remains suitable and safe during shelf-life and the period of its use by consumers. Without preservative ingredients, a cosmetic product would likely pose a risk to the consumer, have a very limited shelf life and would easily spoil.

Cosmetic products placed on the European Union (EU) market may only contain preservatives that are listed in Annex V (list of preservatives allowed in cosmetic products) of the Regulation (EC) No 1223/2009 on cosmetic products, subject to conditions (e.g., concentration limits). (see previous post)

The 4 main parabens used in cosmetic products in the EU are Methylparaben, Propylparaben, Ethylparaben and Butylparaben. But there are several other parabens included in Annex V of the European Cosmetic Products Regulation are: potassium ethylparaben; potassium paraben; sodium methylparaben; sodium ethylparaben; sodium paraben; potassium methylparaben; calcium paraben; hexamide diparaben; hexamide paraben; sodium propylparaben; sodium butylparaben; potassium butylparaben; potassium propylparaben.

Isobutylparaben (and salts), isopropylparaben (and salts), pentylparaben, benzylparaben, phenylparaben are included in Annex II of the Regulation, so they are not allowed in cosmetic products in the EU.

PARABENS SAFETY

Over the years, parabens have subjected to several safety evaluations by the European Commission’s Scientific Committee on Consumer Safety (SCCS). The SCCS has reviewed the scientific data on potential health effects and published its opinions regarding the safety of parabens.

The main concern regarding parabens in cosmetics is the potential of some of them to act like hormones in the body, in particular like estrogens.

In its first opinion, issued in 2005 (SCCP/0873/05), the Scientific Committee on Consumer Products (SCCP) asked for more data on propyl, isopropyl, butyl and isobutyl paraben in order to formulate a final statement on the maximum concentration considered safe in cosmetics. In another opinion (issued on the same year, SCCP/0874/05), the SCCP addressed the relation between parabens, underarm cosmetics and breast cancer. The Scientific Committee concluded that there was insufficient data to establish a clear link between the use of underarm cosmetics and breast cancer.

In 2008 (SCCP/1183/08), the SCCP was of the opinion that, “based upon the available data, the safety assessment of Propyl and Butyl Paraben cannot be finalized yet”. Regarding the potential endocrine modifying effects of parabens of higher chain length, concern was expressed. Estrogenic properties of parabens seemed to increase with increasing chain length, based on in vitro and in vivo rodent test results (available at the time). Nevertheless, the SCCS concluded in 2010 (SCCS/1348/10) that the use of Propylparaben and Butylparaben as preservatives in finished cosmetic products was safe to the consumer, as long as the sum of their individual concentrations does not exceed 0.19%.

Overall, for smaller paraben molecules (Methyl and Ethylparaben), the SCCS considers that they are safe for human health at the maximum authorized concentrations (0.4% for one ester and 0.8% when used in combination). When it comes to longer paraben molecules (Propyl and Butylparaben), the SCCS recommends a lower limit (maximum total concentration of 1.9 g/kg parabens).

Considering the potential endocrine disrupting properties of Propylparaben, the SCCS published an opinion in 2021 where it concludes that this ingredient is “safe when used as a preservative in cosmetic products up to a maximum concentration of 0.14%“. (see previous post)

If you wish to get more information on this or other subject, feel free to contact us at info@criticalcatalyst.com.

References:

  1. Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products.
  2. Scientific Committee on Consumer Products (SCCP). Extended Opinion on the Safety Evaluation of Parabens. SCCP/0873/05. 2005.
  3. Scientific Committee on Consumer Safety (SCCS). Opinion on Propylparaben (PP). SCCS/1623/20. 2021. 

further
reading

cosmetic products

Citral under review: SCCS Preliminary Opinion

The SCCS was tasked by the European Commission to evaluate if the safety levels for Citral, determined through QRA2 based on skin sensitization induction, are sufficient to safeguard consumers. A preliminary opinion was released.

Read More »
cosmetic products

Are sunscreens with Benzophenone-4 safe?

Benzophenone-4 is commonly known as a UV-filter in cosmetic products. Learn what the final opinion of SCCS states about Benzophenone’s safety profile as a UV-filter in cosmetic products.

Read More »
cosmetic products

Is Aluminium in cosmetics safe for human health?

The Scientific Committee on Consumer Safety (SCCS) published its Final Opinion on the safety of Aluminium in cosmetic products. This follows a lengthy review process that began in 2013 when the SCCS was first mandated to evaluate the potential health risks of Aluminium (Al) and its compounds in cosmetics.

Read More »
cosmetic products

Silver in Cosmetics: SCCS preliminary opinion.

Ingredients: SILVER

The recent preliminary opinion from the Scientific Committee on Consumer Safety (SCCS) regarding silver in cosmetics is crucial for consumers and manufacturers. This article breaks down the key points, making it easier to understand the implications and stay informed.

Read More »
news & updates

EU Ecolabel adoption and recognition are on the rise

The Ecolabel certification is a comprehensive program focused on fostering sustainable practices. It evaluates products based on life cycle assessments, where every phase of said life cycle must abide by strict standards to attain the Ecolabel certification. The overarching objective of this certification is minimizing environmental harm from production or consumption activities.

Read More »
cosmetic products

UK proposes ban of wet wipes containing plastic 

The UK has proposed, on April 24, 2024, a regulation titled The Environmental Protection (Wet Wipes Containing Plastic) (England) Regulations 2024, to the World Trade Organization (WTO). The regulation aims to eliminate the supply and sale of plastic-containing wet wipes, including cosmetic ones. The public can offer comments on the draft until June 23, 2024, with adoption expected in September of the same year.

Read More »
news & updates

SCCS preliminary opinion on Citral sensitization endpoint

Ingredients: CITRAL

Date of publication: 27/03/2024

On March 27 2024, the Scientific Committee on Consumer Safety (SCCS) published the Preliminary Opinion on the safety of Citral in cosmetic products. The deadline for comments is set to June 2, 2024.

Read More »
medical devices

Safety Reporting in Clinical Investigations: a Gap Analysis of Guidance Documents 

Safety reporting in clinical investigations of medical devices shall be performed in line with Article 80(2) of the EU MDR. On May 2020, it was published the MDCG 2020-10/1, outlining the procedures for safety reporting in clinical investigations of medical devices under the EU MDR. However, on October 2022 the Medical Device Coordination Group (MDCG) published an updated version of the MDCG 2020-10/1, the MDCG 2020-10/1 Rev 1. This article highlights the updates included in the new revision, analysing the gaps between both documents.

Read More »
medical devices

Roles and Responsibilities of an Authorised Representative under EU MDR and IVDR 

If a medical device manufacturer is not established in a Member State, the devices can only be placed on the Union market if the manufacturer designates an authorised representative. The authorised representative plays a pivotal role in ensuring the compliance of the devices with EU regulation, serving as point of contact. The obligations and responsibilities of authorised representative are outlined on Article 11 of both MDR and IVDR, but clarification of relevant requirements is described in MDCG 2022-16 of October 2022.

Read More »
medical devices

Understanding the ISO Standards Lifecycle

ISO Standards cover a huge range of activities, representing the distilled wisdom of people with expertise in their subject matter and providing the regulators with a sound basis to develop better legislation. ISO Standards are diverse, addressing from the shoe size we wear to the quality of air we breathe. The medical device sector is no exception. ISO has many International Standards and guidance documents aimed at helping the sector ensure safe and effective medical devices while meeting the multitude of national, regional and international regulatory requirements. But how exactly is a Standard developed, reviewed and withdraw?

Read More »